Site map
An overview of the available content on this site. Keep the pointer still over an item for a few seconds to get its description.
-
News
- Herbicide resistance crisis targeted by new Oxford tech firm MoA Technology
- Theolytics Limited comes out of stealth mode with Dr Ken Powell announced as Chair of the Board
- The BioEscalator officially launches
- PepGen receives a £1.6M grant from Innovate UK
- Base Genomics raises $11M
- Theolytics announced winners of the Santander Pitch Finale
- Ervaxx rebrands as Enara Bio
- MiroBio graduates From the BioEscalator
- Agile start-ups partner with academics to find COVID-19 solutions
- Alchemab Announced as Finalists for OBN Awards 2020
- UK-based Alchemab partners with Amii to accelerate the development of novel therapeutics to cure disease
- Base Genomics acquired by Exact Sciences for $410M
- Enara Bio moves to The Oxford Science Park
- PepGen raises $45M Series A
- Theolytics Raises £5M ($6.8M) Series A round Co-led by Epidarex Capital and Taiho Ventures
- Boehringer Ingelheim and Enara Bio enter strategic collaboration and licensing agreement to discover novel shared antigens for cancer immunotherapies
- MediMabBio raises ₩18B (£11.4M) series A funding
- Alchemab raises £60M series A funding
- MoA Technology secures further funding
- MoA Technology graduates from The BioEscalator
- Alchemab moves on from the BioEscalator
- MediMabBio establishes a bridgehead for the development of immuno-oncology drugs in the UK
- PepGen announces closing of $112.5M crossover financing to advance transformative therapies for neuromuscular diseases
- Theolytics graduates from the BioEscalator
- BioEscalator companies attract record funding as investors switch-on to biotech
- HRH The Earl of Wessex visits Oxfordshire virtually
- Oxford BioEscalator celebrates three years of innovation
- Ochre Bio shortlisted as an OBN Awards 2021 finalist in the BioSeed ‘One to Watch’ Category
- Alchemab Therapeutics wins Best Start-up Biotech Company at the OBN Awards 2020
- BioEscalator Pitch Battle 2021
- Gene Linked to Doubling the Risk of Death due to COVID-19 Identified Using Technology Exclusively Licensed to Nucleome Therapeutics
- Exact Sciences Innovation graduates to The Oxford Science Park
- Ochre Bio Raises $9.6M to Advance RNA Therapies for Liver Diseases
- Exogene selected for KQ Labs accelerator programme
- BioEscalator sponsors Oxford Catalyse Programme 2022
- BioEscalator opens new laboratory
- Kyttaro enters Worldwide Exclusive Licensing Agreement with Eli Lilly for Antibody Therapeutic Programme
- Exogene Raises $2M (£1.5M) for Its AI Platform to Discover Cell Therapies for Cancer
- Kyttaro Announces an Exclusive Worldwide Licensing Agreement with Oxford University Innovation
- Nucleome Therapeutics shortlisted as a finalist for the 2022 Oxfordshire Business Awards
- Ochre Bio has announced the launch of its ‘Liver ICU’ in the US to Evaluate Effects of RNA Therapies on Human Liver Performance
- Introducing Oxford Cancer Analytics
- Introducing Oxford Silk Phage Technologies
- Introducing OxVax
- Introducing Alethiomics
- SIGA Announces Preclinical Oncology Research Collaboration with Bioarchitech
- Introducing Kyttaro
- Ochre Bio Enters into Charitable Donation Agreement with British Liver Trust
- Introducing Evolvere Biosciences
- Introducing PepGen
- Introducing Exogene
- Evolvere Biosciences joins the BioEscalator community after winning the OUBT Biohackathon 2021
- Introducing MediMab Biotherapeutics
- Introducing Accunea
- Introducing CyanoCapture
- Oxford Seed Fund announces 2020 investments in Hutano Diagnostics
- Introducing Singula Bio
- Oxford Silk Phage Technologies awarded three consecutive grants from OxLEP’s ISfB programme
- BioEscalator Pitch Battle 2022
- Tours and tenant talks at the BioEscalator open afternoon
- PepGen announced its first participant dosed in a Phase 1 clinical trial of PGN-EDO51 for the treatment of Duchenne Muscular Dystrophy
- PepGen Announces Pricing of Initial Public Offering
- CyanoCapture moves on from the BioEscalator
- PepGen graduates from the BioEscalator
- Introducing Theraport
- Fun in the sun at BioEscalator's Party in the Park
- The BioEscalator holds its first mini supplier show
- OSPT selected by INCATEurope as one of the 6 new ventures to receive Stage I support
- Mental health in the SME community
- The BioEscalator bids farewell to Nucleome Therapeutics
- Alethiomics and Infinitopes shortlisted in the New Startup of the Year category for the Cancer Research Horizons Innovation & Entrepreneurship Awards 2022
- Ochre Bio outgrows the BioEscalator
- Connecting startups to cutting-edge laboratory facilities in Oxford
- BioEscalator Laboratory Manager nominated for Apprentice Manager Award
- Building bonds beyond the lab: BioEscalator's Party in the Park 2023
- BioEscalator Pitch Battle 2023
- BioEscalator presented with LEAF Bronze Award at the Vice Chancellor’s Environmental Sustainability Awards 2023
- Celebrating 5 years of the Oxford BioEscalator
- BioEscalator Apprentice Laboratory Technician nominated for Intermediate & Advanced Apprentice Award
- Hutano Diagnostics acquired by EDX Medical Group
- Oxford Silk Phage Technologies wins BioCap 2023 pitch competition
- Infinitopes has a double victory at the 15th Annual OBN Awards 2023
- Inspiring stories shared at The Africa Oxford Health Innovation platform programme
- It started with a brainstorm
- Granza Bio: Pioneering personalised and targeted cancer therapeutics
- CardiaTec joins the BioEscalator - AI in cardiovascular drug discovery
- Biohackathons, boot-strapping and Innovate UK backing – how Evolvere Biosciences is tackling antimicrobial resistance
- MediMabBio - Two time zones, one mission
- Integrated cancer biotech Infinitopes secures £12.8M seed financing to enhance its Precision Immunomics(TM) antigen discovery technologies to target five more cancers
- BiotechTV explores the BioEscalator's role in nurturing start-ups
- MediMabBio's graduation from the BioEscalator: A testament to innovation and growth
- GSK enters into a multi-year data licence agreement with Ochre Bio to further investigate the drivers of liver disease
- OSPT Ltd brings together ideas and experience for ‘astonishing’ success at the BioEscalator
- Collaboration in action: Academic-industry stories
- Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments
- Highlights from the 5th annual BioEscalator Pitch Battle 2024
- Nucleome Therapeutics appoints Mark Bodmer as Chief Executive Officer
- Moa harvests global deal for new herbicide
- Bioarchitech graduates from the BioEscalator: A new chapter for innovative cancer therapy
- RE-AIM Therapeutics: Targeting disease causal cells to cure autoimmunity
- The BioEscalator welcomes SiGenex to its growing community
- CyanoCapture continues to make strides in the green sciences industry
- Alchemab advances a novel antibody with potential in Parkinson’s disease with support from The Michael J. Fox Foundation
- U-Ploid thrilled to join the BioEscalator Community
- Evolvere Biosciences accepted into the prestigious Y Combinator program
- Eterna Biologics: Revolutionising RNA therapeutics
- Moa announces international field trial success at the ACS autumn conference in Denver
- CardiaTec secures $6.5M seed funding to advance its multi-omics drug discovery platform for cardiovascular diseases
- A plant sciences spin-out flourishes at the BioEscalator
- Moa and Biomar announce bio-herbicide collaboration
- Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®
- Leading academics and innovators join refreshed BioEscalator Management Board
- Moa’s ground breaking science features in journal Weed Science
- Internationally renowned academic Lee Sweetlove joins Moa
- Nucleome Therapeutics announces a strategic collaboration with Johnson & Johnson* to map genetic associations linked to autoimmune disease
- Infinitopes to showcase breakthroughs on cancer vaccine development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial
- Theolytics doses first patient in Phase I/IIa Trial of THEO-260 in ovarian cancer
- OMass Therapeutics appoints Professor Steven Charlton as Chief Scientific Officer
- OMass Therapeutics expands development team with key appointments in US and UK and announces the nomination of clinical candidate against MC2
- CyanoCapture at the Forefront: H2Boost deployment and COSEC Horizon grant to scale biogenic CO2 capture
- Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer
-
Events
- Santander Pitch Finale
- Ice Skating Social
- BioE Xmas Quiz 2019
- Enterprising Women: Lunch and Learn
- Commercialisation Workshops
- Industry Insights Seminar Series
- Impactful Communications to Engage, Motivate & Inspire your People upon their Return to Work'
- Knowledge for growth 2020
- BioBeat 20
- BioCentury and BIA present: Company building in a COVID-19 world
- BIA-MHRA Regulatory Innovation Conference 2020
- BIA Networking Lunch Oxford
- Women in Biotech - Virtual Event
- Industry Insights Seminar Series
- Industry Insights Seminar Series
- EIT Health Investor Network webinar for start-ups
- MedCity and the KPBMA on the Evolution of Immuno-Oncology Webinar
- OBN Digital Event: 'An Update on Market Access into Europe'
- GroWISE Enterprising Women: Commercialising Research with Devika Thapar
- DIT-Biopharmaceutical Virtual Mission- India
- Crick Cancer Research Symposium
- OBN Digital Event: 'Accelerating Drug Discovery' Kindly hosted by Twist Bioscience
- BioJapan 2020
- UK Bioscience Forum: Emerging Data Technologies
- Panel Discussion: How do universities deliver economic value?
- Drug Discovery Digital
- MedTech Integrates
- Bio Integrates 2020
- Pharma Integrates 2020
- CGT Catapult Advanced Therapies Seminar with the University of Oxford
- Due Diligence Live: A Real-Time Pitching Event
- PULSE Check – IP considerations for start ups and spin outs
- Digital BioTuesday: 'An Insight to the Role of Biobanks in Life Sciences R&D Innovation'
- Enterprising Women Lunch and Learn - Nessa Carey: How many careers will you have?
- BioForward
- Women in Healthcare Innovation - The Hill
- 17th Annual bioProcessUK Conference 2020
- PULSE Check – How to land a winning investor pitch
- OBN BioLearn: Presentation Skills for Scientists
- OBN BioLearn: How the Drug Discovery Industry Works
- OBN Digital Event: 'Maximising formulation flexibility in First-In-Human Trials'
- OBN Digital: 'An Exchange of Best Practice: How to Mobilise Real World Datasets to Accelerate Life Sciences R&D'
- Britain's Great Life Sciences Future Genomics, Personalised Medicine and AI Ping Virtual Conference 2020
- Women in Biotech - Manchester
- Brexit Briefing Webinar - November
- Collaboration opportunities with Medicines Discovery Catapult (MDC)
- The AHSN Network Market Insight Briefings
- OBNs BioLearn: Pharmacovigilance for Social Media
- JoinHealth - Autumn welcome webinars: R&D data collection and sharing
- EIT Health - Scaling Up Innovation
- Oxford Talks: Genomics of inflammatory endophenotypes
- OBN Digital BioTuesday: The Future of Workspaces
- Genesis Digital 2020
- OBN Digital Briefing: An Insight into the National Security and Investment Bill
- Industry Insights Seminar Series: Exosome-based therapies for the treatment of rare genetic diseases
- Industry Insights Seminar Series: Targeting the Aryl Hydrocarbon Receptor (AHR) as a novel immunotherapy for the treatment of cancer
- Advanced Therapy Showcase - Tokyo
- Medicine at the Crick - The new medicine of DNA repair pathways: damage repair vulnerabilities in cancer
- Information Session for Oxford MBA Entrepreneurship Project - Collaborators
- BioTrinity 2021
- Growing Your Team: Contractors, Interns, Apprentices and the Kickstart Scheme
- OBN Digital Event: Guide to Company Valuation for Life Sciences
- Enterprising Oxford Webinar – Finding and funding entrepreneurial ideas
- Thought Leadership and Content Strategy
- Oxford Talks - CRISPR-Cas9: Genome Editing and the Future of Medicine
- Health Data Research - all matters data and all data matters
- Innovation Workshop: Innovation through collaboration
- Oxford Talks: Immune system disorders in the workplace
- N-Site Expert Advice Clinic
- OxLEP Skills for Business: Structuring for High Performance
- OxLEP Skills for Business: Scaling Your Business for Growth
- OxLEP Skills for Business: Managing a Remote Workforce
- OBN Digital: CEO Interview with Prof Adrian Hill
- Meet the clinician – Cancer day
- Advanced Therapies Connect
- OBN Digital BioThirstday - sponsored by Results Healthcare
- IDEA (Increasing Diversity in Enterprising Activities) Launch
- OBN Digital: OBN Member Lunch-hour Intellectual Property Clinic
- OXFO Elevate Accelerator - Applications open for Cohort 4
- OxLEP Webinar - How to Prepare and Submit a Grant Funding Application
- OBN BioLearn: Managing Remote Working
- OxLEP Webinar - An Investor's Perspective: What do they look for?
- OSEFx 2021 – Oxford Saïd Entrepreneurship Forum
- Oxford Brooke's Webinar - Women in Innovation: Closing the gender gap
- Women in Biotech - Transatlantic
- BioSeed Lunchtime Express
- International Women’s Day Virtual Networking Event #ChooseToChallenge
- SEHTA: Finding Funding Workshop Webinar
- Ask the Expert - Innovate UK
- Industry Insights Seminar Series: Transforming the path for equitable access to rapid diagnostics for epidemics
- Biotechgate Digital Partnering
- OBN Digital BioTuesday: How Disruptive will RNA Technology be for Drug Discovery in Life Sciences
- OBN Digital BioTuesday: Supporting the Life Sciences Innovation Ecosystem in Oxfordshire
- Pitchfest 2021-2022: Investment Readiness Offering for UK SMEs
- IDEA - Ask Me Anything with Diana Torgersen
- Industry Insights Seminar Series: Accelerating COVID-19 antibody discovery through industry-academia consortium
- Innovation During Lockdown - Speak to the Advisers
- OBN Digital: Is the UK equity capital market still an attractive listing environment for life science companies?
- Thermo Fisher Live From The Lab: When Automation & Robotics meets Acoustic Focusing Technology
- BIA Start-up Festival
- OBN Digital BioThirstday Kindly Supported by Barker Brettell
- Revolutionising healthcare innovation: Putting communities first
- Life Science Leadership Summit
- Emerging Technologies Competition 2021
- Learning from a crisis: How to embed healthcare innovations in challenging times
- R&D Tax - What you need to consider
- Supporting Women for Board Success
- Building the IDEA Community
- BIA Brexit Briefing Webinar
- COVID Conversations Going Viral with Dara Ó Briain
- Building Life Science Adventures
- OxLEP Business Webinar: Resources for Innovation at Begbroke and the University of Oxford
- Oxford AHSN Accelerator Commercialisation Workshops
- Save the Date…. MedCity Investment Hub Showcases for 2021/22.
- Bio Integrates 2021
- Advanced Therapies Congress 2021
- Oxford AHSN Accelerator Commercialisation Workshops
- Oxford AHSN Accelerator Commercialisation workshops
- OBN Digital BioTuesday: How to Structure your IP to Attain Maximum Value at Exit
- OBN Digital CEO Interview: Meet the Finalists, OBN Awards 2020 - Best Established Biotech Company
- Diversity in Biotech
- Industry Insights Seminar Series: Improving drug delivery in ophthalmology
- OBN Digital Event: Building an Innovative Life Sciences Company
- OBN BioLearn: Presentation Skills for Scientists
- Innovate UK Loan Briefing Webinar
- Innovate UK Innovation Loans Competition
- Investing in Women-led Start-ups and Spinouts
- Good Governance: Forming & Managing A Board
- BIA Procurement Professionals Seminar
- L’Oréal-UNESCO UK and Ireland - For Women in Science Rising Talent Programme
- BIO Digital 2021
- MPD Training Course: Medical Device Regulation in the EU, GB & NI
- BIA Garden Party 2021
- OncoStars - Applications open
- BioEscalator Grow On Space 2021
- BioEscalator Pitch Battle 2021
- Industry Insights Seminar Series: Tumour Reengineering
- Opportunities for Commercial-Academic Collaborations with Oxford Cancer Research
- OBN Awards 2021
- OBN CEO Interview Getting to know David Loew, CEO of Ipsen
- Life Sciences Baltics Digital forum
- BioForward 2021
- Knowledge for Growth 2021
- OBN BioLearn: HR Essentials
- OBN BioLearn: How the Drug Discovery Industry Works
- Finding Funds for Innovation
- Winning Innovation Funding Improving your Chances of Success
- Women in Innovation Awards 2021/22 Briefing Event
- Accelerating Drug Discovery through digital and AI innovations
- UK Bioscience Forum 2021
- CRUK Shine Night Walk 2021
- CRUK City of London Centre 2021 Cancer Evolution Symposium
- Industry Insights Seminar Series: Development of Novel Medicines Using High-Resolution Native Mass Spectrometry of Intact Protein Assemblies
- Industry Insights Seminar Series: Humanising Drugs
- The Life Sciences Vision: Making Vision A Reality, With Sir John Bell
- Invest in Innovation
- Medicine at the Crick: Innate Immune Sensing of Nucleic Acids in Medicine
- PING Conference 2021
- UK Life Sciences Industry at the Forefront During COVID-19 Pandemic
- How Does Co-Location Power Life Sciences Innovation?
- Genesis 2021
- N-Site Expert Workshops
- Advanced Therapies Connect
- OxLEP's Start Up Club - Business Planning for Growth
- RisingWISE: An Enterprise Course By and For Women
- BIA-MHRA Regulatory Innovation Conference 2021
- Advanced Therapies Integrates 2021
- OBN Christmas Lecture 2021 - How will the AlphaFold 2 Protein Database Revolutionise Drug Discovery?
- Industry Insight Seminar Series - Translational fellowships: perspectives from a BMS mentor and 5 Oxford fellows
- Fund Your Innovation - Grant Funding with TBAT Innovation
- Industry Insight Seminar Series - Turning Translational Academic Research into Medicines for Patients with Genetic Diseases
- Industry Insight Seminar Series - Combining robotics and AI: the emergence of data-driven drug discovery
- Industry Insight Seminar Series - Gene Therapy Coming of Age
- OBN 'Science Social' Networking Evening
- OBN Digital Webinar: Maximising Your Assets through IP and Regulatory Strategy
- OBN Spring Lecture - The Impact of AlphaFold for Biology and Medicine
- BioTech Bootcamp: Optimising your Business for Success
- BioTrinity 2022: Catalysing Growth in the Life Sciences Industry
- IMAGINE IF! Accelerator for Life Sciences and Health Tech Ventures – Application Deadline 16th February 2022
- Source BioScience Trade Stand
- BioEscalator Mini Supplier Show
- Industry Insights Seminar Series: Physical Modelling and Machine Intelligence for Accelerated Discovery
- Twist Bioscience Seminar: Writing the Future of Biologics - Powering Protein Engineering & Cell Therapies With Synthetic DNA
- BioEscalator Open Afternoon
- PING Conference 2022 - The Golden Age for Life Sciences Innovation
- Innovation Festival – Begbroke Science Park
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- Funding your Innovation: Update on Grants & R&D Tax
- Industry lunchtime talk: Reciprocal Space
- Industry Insights Seminar Series - Natural Cycles: Revolutionising research in Women's Health
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Seminar Series: What apprenticeships can do for your company
- OBN BioTuesday: The importance of getting your company story right from the start
- Optimise your lab operations and improve lab sustainability
- Questions over coffee with the MHRA
- BioEscalator Mini Supplier Show
- University of Oxford laboratory services showcase
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- OBN Science Social
- Managing Sleep and Insomnia Workshop
- BioEscalator Charity Bake Sale
- BioEscalator Laboratory Supplier Exhibition
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- Questions over coffee with the MHRA
- Laboratory sustainability accreditation with LEAF
- BioEscalator Mini Supplier Show
- Innovation Roadshow: OXFORD
- Oxford University Research Facilities Showcase
- Oxford University Research Facilities Showcase
- OBN BioTuesday: A Spotlight on Oncology Precision Prevention Treatments and the Expected Impact on People with High-Risk Conditions
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- Lunch and Learn: How can experimental medicine accelerate your path to candidate selection?
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- BioEscalator Mini Supplier Show
- Lunch and Learn: Key things to consider when starting out in business
- OBN Science Social - BioEscalator